唐人神(002567.SZ):12月生豬銷售收入同升158.64%、環升2.17%
格隆匯1月6日丨唐人神(002567.SZ)披露2022年12月生豬銷售簡報。公司2022年12月生豬銷量28.84萬頭(其中商品豬25.89萬頭,仔豬2.95萬頭),2021年12月生豬銷量12.52萬頭(其中商品豬12.10萬頭,仔豬0.42萬頭),同比上升130.35%,環比上升21.13%;銷售收入合計5.99億元,同比上升158.64%,環比上升2.17%。
2022年1-12月累計生豬銷量215.79萬頭,(其中商品豬189.03萬頭,仔豬26.76萬頭),2021年1-12月生豬銷量154.23萬頭(其中商品豬91.47萬頭,仔豬62.76萬頭),同比上升39.91%;銷售收入42.60億元,同比上升65.73%。
公司表示,2022年12月公司生豬銷量同比、環比上升的主要原因是生豬產能逐步釋放,肥豬出欄增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.